• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA) EPIC SUPRA VALVE W/FLEXFIT; HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA) EPIC SUPRA VALVE W/FLEXFIT; HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Model Number ESP100-21
Device Problems Obstruction of Flow (2423); Incomplete Coaptation (2507); Material Deformation (2976); Material Twisted/Bent (2981)
Patient Problem Aortic Valve Stenosis (1717)
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
The article "very early and unusual aortic bioprosthetic valve deterioration 9 months after implantation" was reviewed.This article is a single case report of a patient who underwent aortic valve replacement with a 21mm epic supra valve on (b)(6) 2020.Nine months post-procedure, he experienced bioprosthesis deterioration of unknown etiology due to inward bending of the stent posts causing leaflet restriction and severe aortic stenosis.The patient refused redo surgery and continued to be symptomatic with dyspnea for the next 2 years until he expired.The primary author is madhu shukla, md, of department of cardiology, jaipur golden hospital, delhi, india.The corresponding author is jagdish c.Mohan, md, with corresponding email: a51hauzkhas@gmail.Com.
 
Manufacturer Narrative
Additional information: h6, h10; correction: h6.As reported in a research article, 9 months after the patient had an epic valve implanted, the stent posts were being inward due to an unknown cause, which resulted in leaflet restriction and stenosis.The patient refused reoperation and had symptoms of dyspnea.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Manufacturer Narrative
Corrected information for: d1 and d4.Originally reported under a 21mm biocor supra valve, but the correct valve is a 21mm epic supra valve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC SUPRA VALVE W/FLEXFIT
Type of Device
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ST. JUDE MEDICAL, BRASIL LTDA. (PAMPULHA)
rua professor jose vieira de mendonça 1301
engenho nogueira - belo horizonte - mg
belo horizonte 31310 -260
BR  31310-260
MDR Report Key10185953
MDR Text Key196224571
Report Number3001883144-2020-00057
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
PMA/PMN Number
P040021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup,Followup
Report Date 12/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/23/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESP100-21
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received07/21/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Other; Required Intervention;
Patient Age72 YR
-
-